GlassScriptPhysician profile
Rubal Patel
NPI 1952543274
$13,040.33
in general payments reported to CMS, 2019-2025
37 companies · $1,844 in 2025
The $1,844 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,922 · 2020: $1,395 · 2021: $1,055 · 2022: $323 · 2023: $5,234 · 2024: $1,267 · 2025: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,698 · Education: $3,000 · Travel and Lodging: $1,633 · Gift: $14.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,698.24 |
| Education | $3,000.00 |
| Travel and Lodging | $1,632.56 |
| Gift | $14.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,316.84 | 2022-2025 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $2,338.37 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Pulmonx Corporation | $1,037.33 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Astrazeneca Pharmaceuticals LP | $931.95 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $923.14 | 2019-2025 | Ofev, Jascayd |
| Sunovion Pharmaceuticals INC. | $527.79 | 2019-2021 | |
| Insmed, INC. | $449.42 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $344.69 | 2019-2025 | Dupixent |
| Philips North America LLC | $243.99 | 2019-2024 | (8874) Incourage, (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $233.97 | 2019-2021 | |
| Genzyme Corporation | $197.86 | 2023-2025 | |
| Pfizer INC. | $166.56 | 2019-2025 | |
| Body Vision Medical INC. | $132.67 | 2023-2024 | Lungvision |
| Grifols USA, LLC | $129.38 | 2019-2024 | Xembify |
| Actelion Pharmaceuticals US, INC. | $110.60 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $99.25 | 2019-2023 | |
| Verona Pharma, INC. | $91.90 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $86.82 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $76.29 | 2019-2025 | Winrevair |
| Takeda Pharmaceuticals U.S.A., INC. | $68.87 | 2023-2025 | Glassia, Cuvitru |
| Abiomed | $53.72 | 2020 | |
| Ambu INC. | $51.07 | 2023 | |
| Baxter Healthcare | $48.11 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Shield Therapeutics INC | $44.52 | 2024 | |
| Ani Pharmaceuticals, INC. | $42.59 | 2023 | Purified Cortrophin Gel |
| Genentech USA, INC. | $40.20 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.86 | 2019-2020 | |
| Abbvie INC. | $32.66 | 2023 | |
| Mallinckrodt Enterprises LLC | $27.05 | 2019 | |
| United Therapeutics Corporation | $24.94 | 2021 | |
| Allergan, INC. | $24.88 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.29 | 2021 | |
| Amgen INC. | $20.02 | 2021 | |
| Shionogi INC | $18.21 | 2023 | Fetroja |
| Janssen Pharmaceuticals, INC | $16.70 | 2023 | Xarelto |
| Portola Pharmaceuticals, LLC | $15.18 | 2019 | |
| Fisher & Paykel Healthcare INC | $14.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rubal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.